The Results of the Hospitalized Treatment of Kerion Celsi
DOI:
https://doi.org/10.3889/oamjms.2023.11575Keywords:
Griseofulvin, Kerion celsi, Incision, Itraconazole, Scalp fungusAbstract
BACKGROUND: Kerion celsi is quite common in children, accounting for a relatively high rate in the form of a scalp fungus, caused by Trichophyton or Microsporum fungi. Clinical manifestations include painful crusty lesions covered with follicular pustules and systemic symptoms. Treatment requires a combination of several methods.
AIM: This study was conducted to describe the results of inpatient treatment of kerion celsi.
METHODS: This is a cross-sectional descriptive study on 25 in-patients with kerion celsi at the National Hospital of Dermatology from January 2017 to December 2017.
RESULTS: The results showed that male patients accounted for 64%, female patients accounted for 36%; 4–7 years old accounted for 52%. The mean number of days of in-patient treatment was 9.9 days. All patients received systemic antifungals in combination with topical antifungals and systemic antibiotics. There were 24/25 patients with incisions, drainage, and pus cleaning. The rate of lesion clearing after 2–4 weeks was 13%, after 4–6 weeks was 34.8%, and over 6 weeks was 52.2%. After 6 months, all patients had hair regrowth. The rate of patients with scars after treatment was 69.6%.
CONCLUSION: Antifungal therapy along with incision, and cleaning of pus gives gcood results in the treatment of kerion celsi, the most common complication is scarring.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
KocabaВ, KarbuzA, c;iftr;i Е, BeQde F,Ametoglou Ѕ, FouadM, et а!. Trichosporon asteroides: Anovel etiological agent of Kerion Celsi in а child. Ј Dr Behcet Uz Child Ноѕр. 2016;6(2):151-4. https://doi.org/10.5222/buchd.2016.151 DOI: https://doi.org/10.5222/buchd.2016.151
Нау RJ. Linea capitis: Current status. Mycopathologia. 2017;182(1-2):87-93. https//doi.org/10.1007/ѕ11046-016-0058-8 PMid:27599708 DOI: https://doi.org/10.1007/s11046-016-0058-8
З. Zaraa 1, Hawilo А, Aounallah А, Trojjet Ѕ. El Euch О, Mokni М, et а!. lnflammatory Tinea capitis: А 12-уеаг study and а review of the literature. Мусоѕеѕ. 2013;56(2):110-6. https://doi. org/10.1111.14З9/0507.201202219.х PMid:22757767 DOI: https://doi.org/10.1111/j.1439-0507.2012.02219.x
lwasawa М, Yorifuji К, Sano А, Takahashi У. Nishimura К. Саѕе of kerion celsi caused by 1/licrosporum gypseum (Arthroderma gypseum) in а child. Nihon lshinkin Gakkai Zasshi. 2009;50(3):155-60. https://doi.org/10.3314/jmm.50.155 PMid:19654448 DOI: https://doi.org/10.3314/jjmm.50.155
Bennassar А, Grimalt R. Management of tinea capitis in childhood. Clin Cosmet lnvestig Dermatol. 2010;3:89-98. https://doi.org/10.2147/ccid.s7992 PMid:21437064 DOI: https://doi.org/10.2147/CCID.S7992
Tinea Capitis: Background. Pathophysiology. Etiology; 2020. Available from: https://emedicine.medscape.com/article/1091351-overview [Last accessed on 2022 Oct 30].
Aste N, Pau М, Biggio Р. Kerion celsi: А clinical epidemiological study. Мусоѕеѕ. 1998;41(3-4):169-73. https://doi.org/10.1111.1439-0507.1998.tb00319.x PMid:9670770 DOI: https://doi.org/10.1111/j.1439-0507.1998.tb00319.x
Fuller LC. Smith СН, Cerio R. Marsden RA Midgley G. Beard AL, et а!. А randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Вг Ј Dermatol. 2001;144(2):321-7. https://doi.org/10.1046/ј.1365-21ЗЗ.2001.04022.х PMid:11251566 DOI: https://doi.org/10.1046/j.1365-2133.2001.04022.x
Gupta АК. Ahmad I, Summerbell RC. Comparative efficacies of commonly used disinfectants and antifungal pharmaceutical spray preparations against dermatophytes fungi. Med Mycol. 2001;39( 4);321-8. https://doi.org/10.1080/mmy.39.4.321.328 PMid:11556761 DOI: https://doi.org/10.1080/mmy.39.4.321.328
Bonven TF, lversen Е, Kragballe К. Permanent hair loss after Kerion Celsi. Ugeskr Laeger.1991;153(45):3151-2. PMid:1957362
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Thi Huyen Tran, Nguyen Van Hoang (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0